TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies. December 7, 2007